7 members of Congress have disclosed 21 trades in Alnylam Pharmaceuticals, Inc. (ALNY) since 2016: 11 purchases worth about $371.01K and 10 sales worth about $320.51K. The most active was Jefferson Shreve, with 1 trade. The latest trade was made on May 12, 2025.
ALNY’s price and SPY’s, both as the change since the start of the range. A green triangle marks a day members bought ALNY, a red one a day they sold; hover for who and how much.
| # | Member | Trades | Buys | Sells | Bought (est.) | Sold (est.) | Net | Buys vs SPY | First Traded | Last Traded |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Jefferson ShreveR-IN | 1 | 0 | 1 | $0.00 | $32.50K | -$32.50K | – | May 12, 2025 | May 12, 2025 |
| 2 | Josh GottheimerD-NJ | 8 | 4 | 4 | $32.00K | $32.00K | $0.00 | -116.5% | Jun 1, 2018 | Jan 29, 2024 |
| 3 | Daniel S. GoldmanD-NY | 2 | 1 | 1 | $32.50K | $32.50K | $0.00 | -106.8% | Jan 31, 2023 | Mar 6, 2023 |
| 4 | Ro KhannaD-CA | 3 | 2 | 1 | $16.00K | $8.00K | +$8.00K | -78.4% | Jun 3, 2019 | Feb 10, 2023 |
| 5 | David P. RoeR-TN | 1 | 1 | 0 | $8.00K | $0.00 | +$8.00K | -96.2% | Jan 6, 2020 | Jan 6, 2020 |
| 6 | Barbara ComstockR-VA | 2 | 1 | 1 | $32.50K | $32.50K | $0.00 | -168.2% | Oct 12, 2017 | Mar 5, 2018 |
| 7 | Richard L. HannaR-NY | 4 | 2 | 2 | $250.00K | $183.00K | +$67.00K | +84.6% | Oct 13, 2016 | Dec 30, 2016 |
| Owner | Type | Filing | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Jefferson ShreveR-IN | ALNYAlnylam Pharmaceuticals, Inc. - Common Stock | Self | Sell | $15K–$50K | May 12, 2025 | Jun 22, 2025 | 41d | -41.5% | -70.5% | |
| Josh GottheimerD-NJ | ALNYAlnylam Pharmaceuticals, Inc. - Common Stock | Joint | Buy | $1K–$15K | Jan 11, 2024 | Feb 15, 2024 | 35d | -19.0% | -76.9% | |
| Josh GottheimerD-NJ | ALNYAlnylam Pharmaceuticals, Inc. - Common Stock | Joint | Sell | $1K–$15K | Jan 29, 2024 | Feb 15, 2024 | 17d | -12.7% | -65.8% | |
| Josh GottheimerD-NJ | ALNYAlnylam Pharmaceuticals, Inc. | Joint | Sell | $1K–$15K | Dec 11, 2023 | Jan 7, 2024 | 27d | -7.6% | -70.4% | |
| Daniel S. GoldmanD-NY | ALNYAlnylam Pharmaceuticals, Inc. | Self | Buy | $15K–$50K | Mar 6, 2023 | Apr 17, 2023 | 42d | -20.9% | -106.8% | |
| Ro KhannaD-CA | ALNYALNYLAM PHARMACEUTICALS, INC. CMN | Spouse | Sell | $1K–$15K | Feb 10, 2023 | Mar 3, 2023 | 21d | -26.6% | -110.9% | |
| Daniel S. GoldmanD-NY | ALNYAlnylam Pharmaceuticals, Inc. | Self | Sell | $15K–$50K | Jan 31, 2023 | Feb 24, 2023 | 24d | -30.2% | -115.3% | |
| Ro KhannaD-CA | ALNYALNYLAM PHARMACEUTICALS, INC. CMN | Spouse | Buy | $1K–$15K | Dec 6, 2022 | Jan 6, 2023 | 31d | -28.1% | -119.0% | |
| Josh GottheimerD-NJ | ALNYAlnylam Pharmaceuticals, Inc. | Joint | Buy | $1K–$15K | Sep 28, 2022 | Oct 16, 2022 | 18d | -25.0% | -128.0% | |
| Josh GottheimerD-NJ | ALNYAlnylam Pharmaceuticals, Inc. | Joint | Sell | $1K–$15K | Nov 13, 2020 | Dec 9, 2020 | 26d | +16.6% | -93.4% | |
| Josh GottheimerD-NJ | ALNYAlnylam Pharmaceuticals, Inc. | Joint | Buy | $1K–$15K | Apr 6, 2020 | May 13, 2020 | 37d | +40.9% | -143.1% | |
| David P. RoeR-TN | ALNY"ALNYLAM PHARMACEUTICALS INC PER AI | Self | Buy | $1K–$15K | Jan 6, 2020 | Feb 14, 2020 | 39d | +36.2% | -96.2% | |
| Ro KhannaD-CA | ALNYALNYLAM PHARMACEUTICALS, INC. CMN | Spouse | Buy | $1K–$15K | Jun 3, 2019 | Jul 11, 2019 | 38d | +136.3% | -37.7% | |
| Josh GottheimerD-NJ | ALNYAlnylam Pharmaceuticals, Inc. | Joint | Sell | $1K–$15K | Oct 18, 2018 | Nov 16, 2018 | 29d | +101.0% | -71.1% | |
| Josh GottheimerD-NJ | ALNYAlnylam Pharmaceuticals, Inc. | Joint | Buy | $1K–$15K | Jun 1, 2018 | Oct 2, 2018 | 123d late | +57.0% | -117.9% |
Tip. Hover a row for the filing’s full asset text and comments; the PDF link opens the report itself.
7 members of Congress have disclosed 21 trades in Alnylam Pharmaceuticals, Inc. (ALNY) since 2016: 11 purchases worth about $371.01K and 10 sales worth about $320.51K. The most active was Jefferson Shreve, with 1 trade. The latest trade was made on May 12, 2025. Most active: Jefferson Shreve (1), Josh Gottheimer (8), Daniel S. Goldman (2), Ro Khanna (3), David P. Roe (1).
Since 2016 they have disclosed 11 purchases and 10 sales; by the midpoints of the disclosed ranges, about $371.01K bought and $320.51K sold, a net purchase of $50.50K.
Members of Congress report each trade over $1,000 within 45 days under the STOCK Act, with the amount as a range. The chart marks the days members traded ALNY on its price, against the S&P 500 over the same days.
Members of Congress disclose trades as dollar ranges, up to 45 days after the trade and sometimes later. Volumes use the midpoints of those ranges and are estimates; portfolio figures are a model built from the disclosed trades, not the members’ actual accounts. Not investment advice.